{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:56:38Z","timestamp":1791420998704,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd004947.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000}}],"reference-count":186,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004947.pub3","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T11:11:05Z","timestamp":1375269065000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth"],"prefix":"10.1002","volume":"2015","author":[{"given":"Jodie M","family":"Dodd","sequence":"first","affiliation":[{"name":"The University of Adelaide, Women's and Children's Hospital; School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology; 72 King William Road Adelaide South Australia Australia 5006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Jones","sequence":"additional","affiliation":[{"name":"The University of Liverpool; Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Flenady","sequence":"additional","affiliation":[{"name":"Mater Research Institute - The University of Queensland (MRI-UQ); Translating Research Into Practice (TRIP) Centre; Level 2 Aubigny Place, Mater Health Services Annerley Road, Woolloongabba Brisbane Queensland Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cincotta","sequence":"additional","affiliation":[{"name":"Mater Mothers' Hospital; Department of Maternal Fetal Medicine; Raymond Terrace South Brisbane Queensland Australia 4101"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A","family":"Crowther","sequence":"additional","affiliation":[{"name":"The University of Auckland; Liggins Institute; Private Bag 92019 85 Park Road Auckland New Zealand"},{"name":"The University of Adelaide; ARCH: Australian Research Centre for Health of Women and Babies, Robinson Research Institute, Discipline of Obstetrics and Gynaecology; Women's and Children's Hospital 72 King William Road Adelaide South Australia Australia 5006"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,31]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rbmo.2012.03.013","article-title":"The use of vaginal natural progesterone for prevention of preterm birth in IVF\/ICSI pregnancies","volume":"25","author":"Aboulghar","year":"2012","journal-title":"Reproductive BioMedicine Online"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0002|cit2","first-page":"11","article-title":"Evaluation of the effect of progesterone on prevention of preterm delivery and its complications","volume":"14","author":"Akbari","year":"2009","journal-title":"Scientific Journal of Kurdistan University of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Borna S Shakoie S Borna H Progesterone for maintenance tocolytic therapy after threatened preterm labor. Randomized controlled trial Journal of Maternal-Fetal and Neonatal Medicine 2008 151 2","DOI":"10.1097\/01.ogx.0000318134.81268.1e"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/j.ajog.2009.10.671","article-title":"Women with prolonged premature rupture of the membrane do not benefit from weekly progesterone: a randomized clinical trial","volume":"201","author":"Briery","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD004947.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SMJ.0b013e3181afee12","article-title":"Progesterone does not prevent preterm births in women with twins","volume":"102","author":"Briery","year":"2009","journal-title":"Southern Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"54.e1","DOI":"10.1016\/j.ajog.2010.08.022","article-title":"Women with preterm premature rupture of the membranes do not benefit from weekly progesterone","volume":"204","author":"Briery","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD004947.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-009-1351-2","article-title":"Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial","volume":"283","author":"Cetingoz","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0011|cit11","first-page":"S168","article-title":"17-hydroxyprogesterone for triplet pregnancy does not reduce prematurity or neonatal morbidity, may increase midtrimester loss","volume":"201","author":"Combs","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0012|cit12","first-page":"S98","article-title":"The impact of maternal weight upon the effectiveness of 17-hydroxyprogesterone in preventing preterm birth among twin gestations","volume":"206","author":"Heitmann","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0013|cit13","unstructured":"Maurel K Combs A 17OHP for reduction of neonatal morbidity due to preterm birth (PTB) in twin and triplet pregnancies http:\/\/controlledtrials.com (accessed 2007)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.ajog.2011.10.484","article-title":"17-hydroxyprogesterone caproate for women with history of preterm birth in a prior pregnancy and twins in the current pregnancy","volume":"206","author":"Combs","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2010.10.018","article-title":"17-hydroxyprogesterone for twin pregnancy: no reduction in prematurity or neonatal morbidity","volume":"204","author":"Combs","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0017|cit17","unstructured":"Maurel K Combs A 17OHP for reduction of neonatal morbidity due to preterm birth (PTB) in twin and triplet pregnancies http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1756-0500-4-568","article-title":"17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial","volume":"4","author":"Combs","year":"2011","journal-title":"BMC Research Notes"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Fonseca","year":"2003","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD004947.pub3-BIB0020|cit20","first-page":"525","article-title":"Uterine contraction monitoring in pregnant women using vaginal natural progesterone","volume":"29 Suppl 1","author":"Fonseca","year":"2001","journal-title":"Journal of Perinatal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/uog.8106","article-title":"Effect of prophylactic progesterone on incidence of preterm labour in spontaneous twin pregnancy, randomized controlled study","volume":"36","author":"Elsheikhah","year":"2010","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD004947.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0028-1085071","article-title":"17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery","volume":"25","author":"Facchinetti","year":"2008","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"453e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2006.10.012","article-title":"17 alpha hydroxy-progesterone caproate (17P) treatment reduced cervical shortening inhibiting cervical interleukin-1 secretion","volume":"195","author":"Facchinetti","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/j.ajog.2009.10.619","article-title":"A randomized placebo controlled trial of oral micronized progesterone to prevent recurrent preterm birth","volume":"201","author":"Glover","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0031-1274509","article-title":"A randomized trial of micronized progesterone for the prevention of recurrent preterm birth","volume":"28","author":"Glover","year":"2011","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0028|cit28","unstructured":"Grobman W RCT of progesterone to prevent preterm birth in nulliparous women with a short cervix http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1016\/j.ajog.2011.10.881","article-title":"Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm","volume":"206","author":"Grobman","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"390.e1","DOI":"10.1016\/j.ajog.2012.09.013","article-title":"17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm","volume":"207","author":"Grobman","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0031|cit31","first-page":"692","article-title":"Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0032|cit32","unstructured":"Hartikainen-Sorri AL Kauppila A Tuimala R Management of twin pregnancy with 17 alpha- hydroxyprogesterone caproate [abstract] 9th World Congress of Gynecology and Obstetrics 1979 October 26-31; Tokyo, Japan 1979 298 9"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mefs.2010.03.007","article-title":"Progesterone supplementation for prevention of preterm labor: a randomized controlled trial","volume":"15","author":"Ibrahim","year":"2010","journal-title":"Middle East Fertility Society Journal"},{"issue":"14","key":"10.1002\/14651858.CD004947.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.ajog.2006.10.490","article-title":"Impact of 17alpha hydroxyprogesterone caproate administration on salivary progesterone and estriol [abstract]","volume":"195","author":"Klebanoff","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0038|cit38","unstructured":"Bruinse HW 17 alpha hydroxyprogesterone in multiple pregnancies to prevent handicapped infants (The AMPHIA Study) http:\/\/www.controlledtrials.com (accessed 2007)"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0041|cit39","first-page":"282A","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on cervical length in multiple pregnancies","volume":"17","author":"Lim","year":"2010","journal-title":"Reproductive Sciences"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0039|cit40","doi-asserted-by":"crossref","unstructured":"Lim AC Bloemenkamp KW Boer K Duvekot JJ Erwich JJ Hasaart TH Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial BMC Pregnancy & Childbirth 2007 7","DOI":"10.1186\/1471-2393-7-7"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0040|cit41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0042|cit42","first-page":"282A","article-title":"Is second trimester cervical length a predictor for an effect of 17-alpha hydroxyprogesterone caproate on neonatal morbidity in multiple pregnancies? Results from the AMPHIA trial (ISRCTN40512715)","volume":"17","author":"Lim","year":"2010","journal-title":"Reproductive Sciences"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0043|cit43","first-page":"S54","article-title":"Mid-pregnancy cervical length as a predictor of preterm birth in multiple pregnancies","volume":"204","author":"Willekes","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India","volume":"29","author":"Majhi","year":"2009","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2009.06.036","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"506.e1","DOI":"10.1016\/j.ajog.2008.03.003","article-title":"Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo","volume":"199","author":"Klebanoff","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ajog.2005.10.173","article-title":"Does gestational age at randomization affect the efficacy of alpha hydroxyprogesterone caproate (17-OHCP) in preventing recurrent preterm delivery? [abstract]","volume":"193","author":"Koontz","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2011.03.048","article-title":"Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate","volume":"205","author":"Manuck","year":"2011","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.ajog.2003.10.396","article-title":"More than one previous preterm delivery and the risk of preterm birth in women treated with 17 alpha-hydroxyprogesterone (17P) [abstract]","volume":"189","author":"Meis","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.AOG.0000174582.79364.a7","article-title":"Does progesterone treatment influence risk factors for recurrent preterm delivery?","volume":"106","author":"Meis","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"24","key":"10.1002\/14651858.CD004947.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD004947.pub3-BIB0052|cit52","first-page":"S54","article-title":"17 alphahydroxyprogesterone caproate prevents recurrent preterm birth [abstract]","volume":"187","author":"Meis","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ajog.2006.10.017","article-title":"4-year follow-up of children exposed to 17alpha hydroxyprogesterone caproate (17P) in utero","volume":"195","author":"Northen","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstetrics & Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0056|cit55","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ajog.2004.10.295","article-title":"Plasma CRH levels at 16-20 weeks do not predict preterm delivery in women at high-risk for preterm delivery [abstract]","volume":"191","author":"Sibai","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD004947.pub3-BIB0055|cit56","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ajog.2005.06.036","article-title":"Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery","volume":"193","author":"Sibai","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0058|cit57","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ajog.2004.09.058","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at prior delivery [abstract]","volume":"191","author":"Spong","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD004947.pub3-BIB0057|cit58","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ajog.2005.05.077","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery","volume":"193","author":"Spong","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0059|cit59","unstructured":"Moghtadaei P Sardari F Latifi M Progesterone for prevention of preterm birth and improvement in pregnancy outcomes among primiparae of advanced maternal age Archives of Disease in Childhood. Fetal and Neonatal Edition 2008 Fa71"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0060|cit60","unstructured":"Moghtadei P Sardari F Latifi M Progesterone for prevention of preterm birth and improvement pregnancy outcomes among primiparae of advanced maternal age Journal of Maternal-Fetal and Neonatal Medicine 2008 122"},{"issue":"S1","key":"10.1002\/14651858.CD004947.pub3-BIB0061|cit61","first-page":"305","article-title":"Treatment with different types of progesterone in prevention of preterm delivery","volume":"23","author":"Ndoni","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0266462310000036","article-title":"Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis","volume":"26","author":"Eddama","year":"2010","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0063|cit63","unstructured":"Norman J Double blind randomised placebo controlled trial of progesterone for the prevention of preterm birth http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"9680","key":"10.1002\/14651858.CD004947.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1933719110395404","article-title":"Effect of prolonged in vivo administration of progesterone in pregnancy on myometrial gene expression, peripheral blood leukocyte activation, and circulating steroid hormone levels","volume":"18","author":"Norman","year":"2011","journal-title":"Reproductive Sciences"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0066|cit66","unstructured":"DeFranco EA O'Brien JM Adair CD Lewis DF Hall DR Fusey S Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial Ultrasound in Obstetrics and Gynecology 2007 697 705"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0067|cit67","doi-asserted-by":"crossref","unstructured":"Defranco E O'Brien J Adair J Lewis DF Hall D Phillips J Is there a racial disparity of progesterone to prevent preterm birth American Journal of Obstetrics and Gynecology 2007 S200, Abstract no: 702","DOI":"10.1016\/j.ajog.2007.10.730"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"O'Brien J Defranco E Adair D Lewis DF Hall D Bsharat M Progesterone reduces the rate of cervical shortening in women at risk for preterm birth: secondary analysis from a randomized, double-blind, placebo-controlled trial American Journal of Obstetrics and Gynecology 2007 S7, Abstract no: 15","DOI":"10.1016\/j.ajog.2007.10.017"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0069|cit69","doi-asserted-by":"crossref","unstructured":"O'Brien J Defranco E Hall D Creasy G Natural progesterone administration and the risk of medical complications of pregnancy: secondary analysis from a multinational, randomized, double blind, placebo-controlled trial American Journal of Obstetrics and Gynecology 2008 S139","DOI":"10.1016\/j.ajog.2008.09.496"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"O'Brien J Defranco E Hall D Phillips J Creasy G Do other elements of the obstetrical history provide a possible indication for progesterone supplementation? Secondary analysis from the progesterone vaginal gel trial American Journal of Obstetrics and Gynecology 2008 S42","DOI":"10.1016\/j.ajog.2008.09.128"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized double blind placebo controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O'Brien","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.ajog.2011.10.508","article-title":"Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"206","author":"O'Brien","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0074|cit74","unstructured":"Papiernik-Berkhauer E Double blind study of an agent to prevent preterm delivery among women at increased risk Edition Schering Serie IV 1970 65 8"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2008.08.029","article-title":"Oral micronized progesterone for prevention of preterm birth","volume":"104","author":"Rai","year":"2009","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"S1","key":"10.1002\/14651858.CD004947.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/uog.9123","article-title":"Vaginal progesterone and the risk of preterm delivery in high-risk twin gestations - secondary analysis of a placebo-controlled randomized trial","volume":"38","author":"Klein","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/uog.9092","article-title":"Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis","volume":"38","author":"Klein","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0080|cit78","unstructured":"Rode L The PREDICT study http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0078|cit79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/uog.9095","article-title":"Prevention of preterm delivery in twin gestations (PREDICT): a multicentre randomised placebo-controlled trial on the effect of vaginal micronised progesterone","volume":"38","author":"Rode","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0079|cit80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/uog.9093","article-title":"Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone","volume":"38","author":"Rode","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2006.10.003","article-title":"A randomized controlled trial of 17-hydroxyprogesterone caproate (17-OHPC) for the prevention of preterm birth in twins","volume":"195","author":"Caritis","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0082|cit82","unstructured":"Caritis SN Simhan H Relationship of 17-alpha hydroxyprogesterone caproate (17-OHPC) concentrations and gestational age at delivery in twins 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 139"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2012.08.001","article-title":"Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0084|cit84","unstructured":"Caritis SN Venkat R Impact of body mass index (BMI) on plasma concentrations of 17-alpha hydroxyprogesterone caproate (17-OHPC) 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 138"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Durnwald C The impact of cervical length on risk of preterm birth in twin gestations American Journal of Obstetrics and Gynecology 2008 S10","DOI":"10.1016\/j.ajog.2008.09.047"},{"issue":"12","key":"10.1002\/14651858.CD004947.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","article-title":"Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17- hydroxyprogesterone caproate","volume":"23","author":"Durnwald","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2009.06.036","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Horton A Gyamfi C 17-alpha hydroxyprogesterone caproate does not increase the risk of gestational diabetes in singleton and twin pregnancies American Journal of Obstetrics and Gynecology 2008 S197","DOI":"10.1016\/j.ajog.2008.09.720"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Manuck T for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) The relationship between polymorphisms in the human progesterone receptor and clinical response to 17 alpha-hydroxyprogesterone caproate for the prevention of recurrent spontaneous preterm birth American Journal of Obstetrics and Gynecology 2008 S18","DOI":"10.1016\/j.ajog.2008.09.059"},{"issue":"7","key":"10.1002\/14651858.CD004947.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1248940","article-title":"Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term","volume":"27","author":"Refuerzo","year":"2010","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 Alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0092|cit92","unstructured":"Simhan HN Caritis SN The effect of 17-alpha hydroxyprogesterone caproate (17-OHPC) on maternal plasma CRP levels in twin pregnancies 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 140"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0095|cit93","unstructured":"Rozenberg P Efficacy of 17 alpha-hydroxyprogesterone caproate for the prevention of preterm delivery http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0093|cit94","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0094|cit95","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2011.10.029","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labour by 17 alpha-hydroxyprogesterone caproate: a randomised controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD004947.pub3-BIB0097|cit96","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1447-0756.2011.01524.x","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in prevention of preterm delivery","volume":"37","author":"Saghafi","year":"2011","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0096|cit97","first-page":"28","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in preterm delivery prevention","volume":"14","author":"Saghafi","year":"2011","journal-title":"Iranian Journal of Obstetrics, Gynecology and Infertility"},{"issue":"S2","key":"10.1002\/14651858.CD004947.pub3-BIB0098|cit98","first-page":"14","article-title":"Prevention of preterm delivery in asymptomatic women with twin pregnancy by 17 alpha-Hydroxyprogesterone caproate: A randomised controlled trial","volume":"25","author":"Senat","year":"2012","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0100|cit99","unstructured":"Serra V Natural progesterone and preterm birth in twins http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0099|cit100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-0528.2012.03448.x","article-title":"Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial","volume":"120","author":"Serra","year":"2013","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0101|cit101","first-page":"45","article-title":"Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: a randomized placebo-controlled double-blind trial","volume":"4","author":"Sharami","year":"2010","journal-title":"International Journal of Fertility and Sterility"},{"issue":"3Suppl","key":"10.1002\/14651858.CD004947.pub3-BIB0102|cit102","first-page":"73A","article-title":"Relationship between cervical-vaginal fluid elafin concentrations and subsequent cervical shortening in women at high risk of spontaneous preterm birth","volume":"19","author":"Abbott","year":"2012","journal-title":"Reproductive Sciences"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000328719","article-title":"Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor","volume":"72","author":"Arikan","year":"2011","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2010.02.019","article-title":"17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length","volume":"202","author":"Berghella","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/j.1879-3479.1979.tb00469.x","article-title":"A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor","volume":"16","author":"Breart","year":"1979","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-9378(16)35945-2","article-title":"Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor","volume":"83","author":"Brenner","year":"1962","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3Suppl","key":"10.1002\/14651858.CD004947.pub3-BIB0107|cit107","first-page":"189A","article-title":"Serum progesterone concentrations in women with a previous preterm birth treated with vaginal progesterone supplementation","volume":"19","author":"Chandiramani","year":"2012","journal-title":"Reproductive Sciences"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of progesterone prophylaxis after midtrimester amniocentesis","volume":"100","author":"Corrado","year":"2002","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0109|cit109","first-page":"205","article-title":"West Area Los Angeles prematurity prevention demonstration project","volume-title":"Prevention of Preterm Birth","author":"Hobel","year":"1986"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0110|cit110","first-page":"112","article-title":"West Los Angeles premature prevention program: significant impact","volume":"15","author":"Hobel","year":"1987","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9378(12)91479-9","article-title":"West Los Angeles preterm birth prevention project (LAPPP): program impact","volume":"166","author":"Hobel","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0112|cit112","first-page":"54","article-title":"The West Los Angeles preterm birth prevention project: I. program impact on high-risk women","volume":"170","author":"Hobel","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0113|cit113","first-page":"Abstract no. 00","article-title":"Randomized trial of cerclage and progesterone to prevent spontaneous preterm brith in high-risk women with a short cervix","volume":"39 Suppl","author":"Ionescu","year":"2012","journal-title":"Journal of Perinatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1515\/JPM.2009.083","article-title":"A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix","volume":"37","author":"Keeler","year":"2009","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0115|cit115","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"Vine","year":"1964","journal-title":"Western Journal of Surgical Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004947.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.ajog.2006.10.375","article-title":"A randomized trial of cerclage versus 17 hydroxyprogesterone for the treatment of short cervix","volume":"195","author":"Rust","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD004947.pub3-BIB0117|cit117","first-page":"538","article-title":"Prevention of preterm labour with progesterone","volume":"69","author":"Suvonnakote","year":"1986","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(66)90173-6","article-title":"Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy","volume":"95","author":"Turner","year":"1966","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14767050500246243","article-title":"Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study. A double blind, prospectively randomised placebo controlled parallel group trial","volume":"18","author":"Walch","year":"2005","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(85)90141-3","article-title":"Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate","volume":"151","author":"Yemini","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0121|cit121","unstructured":"Coomarasamy A First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: a randomised double-blind placebo-controlled multi-centre trial (The PROMISE [PROgesterone in recurrent MIScarriagE] Trial) http:\/\/www.controlled-trials.com\/ISRCTN92644181\/ISRCTN92644181"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0122|cit122","unstructured":"Creasy GW The effect of vaginal progesterone administration in the prevention of preterm birth in women with a short cervix ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/) (accessed 2008)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0123|cit123","first-page":"A29","article-title":"POPPI: prevention of problems of preterm birth with progesterone in women at increased risk: a multicentre randomised controlled trial [abstract]","volume":"43","author":"Armson","year":"2007","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0124|cit124","unstructured":"Ashwood P Progesterone after previous preterm birth for the prevention of neonatal respiratory distress syndrome WOMBAT Collaboration (www.wombatcollaboration.net\/trials)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0125|cit125","unstructured":"Crowther CA Dodd JM McPhee AJ Flenady V Australasian Collaborative Trial of Vaginal Progesterone Therapy (The PROGRESS Trial) http:\/\/controlledtrials.com (accessed 2007)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2393-9-6","article-title":"Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial","volume":"9","author":"Dodd","year":"2009","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0127|cit127","unstructured":"Matrinez de Tajada B Vaginal progesterone to prevent preterm delivery in women with preterm labor http:\/\/controlledtrials.com (accessed 2007)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0129|cit128","unstructured":"Nassar A Prevention of preterm delivery in twin pregnancies by 17 alpha hydroxyprogesterone caproate http:\/\/controlledtrials.com (accessed 2007)"},{"issue":"S1","key":"10.1002\/14651858.CD004947.pub3-BIB0128|cit129","first-page":"307","article-title":"Incidence of GDM in twin pregnancies of women receiving prophylactic 17-A OH progesterone caproate","volume":"23","author":"Nassar","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2393-12-79","article-title":"Trial protocol OPPTIMUM- Does progesterone prophylaxis for the prevention of preterm labour improve outcome?","volume":"12","author":"Norman","year":"2012","journal-title":"BMC pregnancy and childbirth"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0131|cit131","unstructured":"Perlitz Y Prevention of recurrent preterm delivery by a natural progesterone agent http:\/\/controlledtrials.com (accessed 2007)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0132|cit132","unstructured":"Starkey M Comparing IM vs. vaginal progesterone for pre-term birth ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0133|cit133","unstructured":"Swaby C Pilot randomized controlled trial of vaginal progesterone to prevent preterm birth in multiple pregnancy JOGC: Journal of Obstetrics and Gynaecology Canada 2007 S47"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2393-11-77","article-title":"Preventing preterm birth with progesterone: Costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study","volume":"11","author":"Os","year":"2011","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0135|cit135","unstructured":"Wood S Vaginal progesterone versus placebo in multiple pregnancy http:\/\/controlledtrials.com (accessed 2007)"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0136|cit136","first-page":"1115","article-title":"Committee opinion: use of progesterone to reduce preterm birth","volume":"102","author":"American College of Obstetrics and Gynecology","year":"2003","journal-title":"Obstetrics & Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD004947.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.283.12.1591","article-title":"Rates and factors associated with recurrence of preterm delivery","volume":"283","author":"Adams","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0138|cit138","volume-title":"Australia's Mothers and Babies 2000","author":"Australian Institute of Health and Welfare","year":"2003"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008991.pub2","article-title":"Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy","author":"Alfirevic","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0301-2115(02)00422-0","article-title":"The involvement of progesterone in the onset of human labour","volume":"108","author":"Astle","year":"2003","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD004947.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0002-9378(79)90742-7","article-title":"The tendency to repeat gestational age and birth weight in successive births","volume":"135","author":"Bakketeig","year":"1979","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0142|cit142","first-page":"233","article-title":"Epidemiology of preterm birth","volume":"88","author":"Berkowitz","year":"1993","journal-title":"Epidemiologic Reviews"},{"issue":"9832","key":"10.1002\/14651858.CD004947.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0002-9378(84)90674-4","article-title":"Preterm delivery is not predicted by serial plasma estradiol or progesterone concentration measurements","volume":"150","author":"Block","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0145|cit145","first-page":"379","article-title":"Recurrence of preterm birth in singleton and twin pregnancies","volume":"98","author":"Bloom","year":"2001","journal-title":"Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD004947.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-0528.1985.tb03071.x","article-title":"The repetition of spontaneous preterm labour","volume":"92","author":"Carr-Hill","year":"1985","journal-title":"BJOG:an international journal of obstetrics and gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"42.e1","DOI":"10.1016\/j.ajog.2012.10.877","article-title":"Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis","volume":"208","author":"Conde-Agudelo","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"16","key":"10.1002\/14651858.CD004947.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1440-1754.1999.00308.x","article-title":"Hospital admissions in the first year of life in very preterm infants","volume":"35","author":"Elder","year":"1999","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-0528.2004.00059.x","article-title":"How should randomised trial including multiple pregnancies be analysed?","volume":"111","author":"Gates","year":"2004","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199807303390506","article-title":"Prevention of premature birth","volume":"339","author":"Goldenberg","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"6675","key":"10.1002\/14651858.CD004947.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/33176","article-title":"Inhibition of oxytocin receptor function by direct binding of progesterone","volume":"392","author":"Grazzini","year":"1998","journal-title":"Nature"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMe030081","article-title":"Progesterone and preterm delivery - deja vu all over again","volume":"348","author":"Greene","year":"2003","journal-title":"New England Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub2","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1 Suppl E","key":"10.1002\/14651858.CD004947.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1542\/peds.103.SE1.319","article-title":"Consideration of the use of health status, functional outcome, and quality-of-life to monitor neonatal intensive care practice","volume":"103","author":"Hack","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9378(97)70570-2","article-title":"Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys","volume":"176","author":"Haluska","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004947.pub3-BIB0157|cit157","first-page":"125","article-title":"Progesterone receptor localisation and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition","volume":"9","author":"Haluska","year":"2002","journal-title":"Journal of the Society for Gynecological Investigation"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5694\/j.1326-5377.1988.tb120594.x","article-title":"A review of the obstetric and medical complications leading to the delivery of very low birth weight infants","volume":"149","author":"Hewitt","year":"1988","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0160|cit160","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0161|cit161","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mob.2003.194","article-title":"Supplemental progesterone to prevent preterm birth","volume":"188","author":"Iams","year":"2003","journal-title":"American Journal Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ije\/2.2.195","article-title":"Prediction of low birthweight and prematurity by a multiple regression analysis with maternal characteristics known since the beginning of the pregnancy","volume":"2","author":"Kaminski","year":"1973","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"131.e1","DOI":"10.1016\/j.ajog.2006.06.093","article-title":"Racial disparity in the frequency of recurrence of preterm birth","volume":"196","author":"Kistka","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.284.7.843","article-title":"The contribution of mild and moderate preterm birth to infant mortality","volume":"284","author":"Kramer","year":"2000","journal-title":"JAMA"},{"issue":"Suppl 20","key":"10.1002\/14651858.CD004947.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.00023.x","article-title":"Mechanism of labour - biochemical aspects","volume":"110","author":"Lopez-Bernal","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"10","key":"10.1002\/14651858.CD004947.pub3-BIB0167|cit167","first-page":"1","article-title":"Births: final data for 2002","volume":"52","author":"Martin","year":"2003","journal-title":"National Vital Statistics Report"},{"issue":"Suppl. 2","key":"10.1002\/14651858.CD004947.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-3016.2001.00004.x","article-title":"Preterm delivery: a public health perspective","volume":"15","author":"Mattison","year":"2001","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.0004-8666.2002.00353.x","article-title":"Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?","volume":"42","author":"McLaughlin","year":"2002","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD004947.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9378(99)70111-0","article-title":"The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcomes","volume":"181","author":"Mercer","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1515\/jpme.1974.2.1.30","article-title":"Multifactorial study of the risk of prematurity at 32 weeks of gestation: a study of the frequency of 30 predictive characteristics","volume":"2","author":"Papiernik","year":"1974","journal-title":"Journal of Perinatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0173|cit173","first-page":"608","article-title":"Actions of placental and fetal adrenal steroid hormones in primate pregnancy","volume":"16","author":"Pepe","year":"1995","journal-title":"Endocrine Review"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000150560.24297.4f","article-title":"Estimated effect of 17 alpha hydroxyprogesterone caproate on preterm birth in the United States","volume":"105","author":"Petrini","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD004947.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","article-title":"Interactions between progesterone receptor isoforms in myometrial cells in human labour","volume":"7","author":"Peiber","year":"2001","journal-title":"Molecular Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD004947.pub3-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009166","article-title":"Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy","author":"Rafael","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0177|cit177","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0178|cit178","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD004947.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/sper.2001.27548","article-title":"The epidemiology of preterm labour","volume":"25","author":"Robinson","year":"2001","journal-title":"Seminars in Perinatology"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"124: 1-19","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD004947.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2393-12-13","article-title":"Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials","volume":"15","author":"Schuit","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1002\/14651858.CD004947.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000299090","article-title":"Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour","volume":"18","author":"Smit","year":"1984","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2007.03.005","article-title":"A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth","volume":"133","author":"Smith","year":"2007","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD004947.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-3016.1992.tb00769.x","article-title":"Survival and cerebral palsy in low birthweight infants: implications for perinatal care","volume":"6","author":"Stanley","year":"1992","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004947.pub3-BIB0185|cit185","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004947","article-title":"Antenatal administration of progesterone for preventing spontaneous preterm birth","author":"Cincotta","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004947.pub3-BIB0186|cit186","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004947.pub2","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004947.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T02:04:03Z","timestamp":1713837843000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004947.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":186,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004947.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718056405.793505103","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}